Home › Ovarian Epithelial Carcinoma › Tennessee
Ovarian Epithelial Carcinoma clinical trials in Tennessee
6 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Tennessee.
Cities in Tennessee
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Erlanger Health, Chattanooga
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 15, 2026 · NCT06915025Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer
- University of Tennessee Medical Center - Knoxville, Knoxville
RecruitingObservational study
Ages 18 and older · Women · Updated Aug 17, 2026 · NCT07764133AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, Germantown
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Sarah Cannon Research Institute (Oncology Associates of Oregon PC), Nashville
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, Nashville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06756035Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.